Want to learn more about Type 3c Diabetes? Register for our upcoming webinar! 🎉:
In this Mission: Cure patient education webinar, medical experts discuss current clinical trials available to pancreatitis patients. A clinical trial is a research study to test new treatments on people. It is a critical step in the process of getting a new treatment approved so that it can be given to patients. After a treatment, …
New Pancreatitis Therapies: Current Clinical Trials Read More »
Acute pancreatitis, a life-threatening condition, occurs suddenly and is often idiopathic (meaning, for unknown reasons). Although treatment specific to the disease is lacking, it usually resolves with proper clinical management. Multiple episodes may occur over time, leading to recurrent acute pancreatitis, which can eventually lead to chronic pancreatitis. Chronic pancreatitis is irreversible inflammatory and fibrotic …
When will we have new treatments for pancreatitis? In July, Mission: Cure met with researchers and doctors to discuss this important question. Mission: Cure CEO Megan Golden, VP for Translational Research Lola Rahib, and the summer interns attended PancreasFest 2022 at the University of Pittsburgh. PancreasFest is an annual conference that brings together researchers who …
Getting Ready to Test New Pancreatitis Treatments: News from PancreasFest Read More »
Mission: Cure has provided initial funding to Johns Hopkins Medicine to launch the new Pancreatitis Pain Research Center. Mission: Cure will work with Johns Hopkins to establish the Pancreatitis Pain Research Program. The goals for the pancreatitis pain program are: To study and treat specific types of pain associated with chronic pancreatitis To create an …
New Collaboration with Johns Hopkins to Treat Pancreatitis Pain Read More »
https://youtu.be/I7XM-fdapvs Mission: Cure’s webinar on February 23rd, 2022 featured three biotech executives who are searching for a cure for pancreatitis and one of its major complications, diabetes. John Mellnik, CEO of Path BioAnalytics (PBA), discusses their most recent project that uses translational science and proprietary technology to identify drugs that will correct the problems in …
We are elated to announce that Healx, an AI-powered technology company that shares our passion for patient-centered care, has chosen to team up with Mission: Cure to help find a cure for chronic pancreatitis! Mission: Cure was chosen from among many rare disease organizations to be part of Healx’s Rare Treatment Accelerator Program (RTA) with …
Pancreatitis Externally-Led Patient-Focused Drug Development Meeting Mission: Cure was one of many patient advocacy nonprofit organizations that participated in the development of the very first Voice of the Patient Report, a months-long project led by the National Pancreas Foundation. In March, during the Patient-Focused Drug Development (PFDD) meeting, Co-Founder and pancreatitis patient Eric Golden shared …
https://www.youtube.com/watch?v=hZGd5QhjrKc&t=2s On this webinar, Kate Nicholson, J.D., a civil rights attorney, pain patient advocate, and expert on the so-called opioid or overdose crisis, and Dr. Eva Szigethy, a leading UPMC psychiatrist focused on the management of chronic pain and psychotropic medication management in patients, discuss: Barriers to care for patients who use opioids The opioids …
Pancreatitis Pain: The Latest Treatment & Policy Perspectives on Opioids Read More »
On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month “datathon” aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures …
Potential Chronic Pancreatitis Treatments Identified Read More »
Before You Go
Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.